U.S. PHARMACOPEIA

Search USP29  
Bacitracin

Bacitracin.
Bacitracin [1405-87-4].
» Bacitracin is a polypeptide produced by the growth of an organism of the licheniformis group of Bacillus subtilis (Fam. Bacillacaea). It has a potency of not less than 40 Bacitracin Units per mg.
Packaging and storage— Preserve in tight containers, and store in a cool place.
Labeling— Where it is packaged for prescription compounding, label it to indicate that it is not sterile and that the potency cannot be assured for longer than 60 days after opening, and to state the number of Bacitracin Units per milligram. Where it is intended for use in preparing injectable or other sterile dosage forms, the label states that it is sterile or must be subjected to further processing during the preparation of injectable or other sterile dosage forms.
Thin-layer chromatographic identification test 201BNP: meets the requirements.
pH 791: between 5.5 and 7.5, in a solution containing 10,000 Bacitracin Units per mL.
Loss on drying 731 Dry about 100 mg in a capillary-stoppered bottle in vacuum at a pressure not exceeding 5 mm of mercury at 60 for 3 hours: it loses not more than 5.0% of its weight.
Residual solvents 467: meets the requirements.
(Official January 1, 2007)
Other requirements— Where the label states that Bacitracin is sterile, it meets the requirements for Sterility Tests 71 and, where intended for injectable dosage forms, for Bacterial endotoxins under Bacitracin for Injection. Where the label states that Bacitracin must be subjected to further processing during the preparation of injectable dosage forms, it meets the requirements for Bacterial endotoxins under Bacitracin for Injection.
Assay— Proceed with Bacitracin as directed under Antibiotics—Microbial Assays 81.
Auxiliary Information— Staff Liaison : Brian D. Gilbert, Ph.D., Scientist
Expert Committee : (MDANT05) Monograph Development-Antibiotics
USP29–NF24 Page 233
Pharmacopeial Forum : Volume No. 28(4) Page 1069
Phone Number : 1-301-816-8223